MV
MVF.AU Monash Ivf Group Ltd
- Market cap
- AUD 281M
- P/E
- 36.0x
- P/B
- 1.13x
- ROE
- 3.0%
- Dividend yield
- 1.67%
- Fundamental score
- 0.9/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is MVF.AU undervalued?
Graham numberMVF.AU trades 34.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Monash Ivf Group Ltd fundamental analysis
5 of 22 checks passedROE 0/2
Low return on equity (3.0%), below 10%.
ROA 1/1
Return on assets (1.4%) is above the industry median (-51.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-70.3%) is not above the 5-year average (-21.6% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-70.3%) is below the industry median (-5.3%).
Revenue Growth 1/2
Revenue grew 8.1% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (80.1%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is 2.2x against interest expense, below 5x.
PE vs Market 0/1
PE (36.0x) is above the market median (15.0x).
PE vs Industry 0/1
PE (36.0x) is above the industry median (16.3x).
PBV 1/1
Price to book (1.1x) is below the industry median (4.4x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 40.5, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield (1.7%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 63.0%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Monash Ivf Group Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Full company profileMonash Ivf Group Ltd financial statements
Monash Ivf Group Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 155M | 151M | 152M | 145M | 184M | 192M | 214M | 255M | 272M | 269M |
| Gross Profit | 68.4M | 59.9M | 52.9M | 38.4M | 57.7M | 57.2M | 63.4M | 85.5M | 90.3M | 61.9M |
| Operating Income | 44.6M | 33.2M | 32.7M | 16.9M | 35.1M | 30.9M | 33.1M | -5.61M | 43.4M | 20.7M |
| EBITDA | 49.0M | 38.1M | 36.5M | 32.8M | 51.2M | 43.2M | 48.5M | 10.8M | 66.2M | 44.0M |
| Net Income | 29.6M | 21.4M | 19.9M | 11.7M | 25.1M | 18.4M | 21.8M | -6.53M | 25.0M | 7.43M |
| EPS | 0.13 | 0.09 | 0.08 | 0.04 | 0.06 | 0.05 | 0.06 | -0.02 | 0.06 | 0.02 |
| Balance Sheet | ||||||||||
| Total Assets | 287M | 291M | 290M | 354M | 356M | 387M | 422M | 508M | 493M | 512M |
| Total Liabilities | 124M | 124M | 117M | 102M | 87.7M | 117M | 147M | 262M | 242M | 259M |
| Shareholders' Equity | 164M | 167M | 173M | 250M | 266M | 268M | 273M | 242M | 246M | 249M |
| Cash & Short-term Investments | 3.50M | 3.85M | 4.28M | 15.1M | 8.76M | 7.87M | 8.01M | 11.3M | 9.43M | 8.84M |
| Total Debt | 95.7M | 98.1M | 94.4M | 57.6M | 46.0M | 77.2M | 100M | 135M | 180M | 200M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 25.9M | 25.9M | 33.1M | 31.1M | 44.0M | 31.9M | 39.1M | 52.5M | 12.9M | 30.2M |
| Capital Expenditure | 6.60M | 6.56M | 6.54M | 7.51M | 10.0M | 11.8M | 27.8M | 20.8M | 12.4M | 22.9M |
| Free Cash Flow | 19.3M | 19.4M | 26.6M | 23.6M | 33.9M | 20.1M | 11.3M | 31.7M | 468K | 7.27M |
| Ratios | ||||||||||
| ROE | 18.1% | 12.8% | 11.5% | 4.7% | 9.4% | 6.9% | 8.0% | -2.7% | 10.2% | 3.0% |
| ROA | 10.3% | 7.3% | 6.8% | 3.3% | 7.1% | 4.8% | 5.2% | -1.3% | 5.1% | 1.4% |
| Net Profit Margin | 19.1% | 14.2% | 13.1% | 8.1% | 13.7% | 9.6% | 10.2% | -2.6% | 9.2% | 2.8% |
| Debt to Equity | 0.59x | 0.59x | 0.54x | 0.23x | 0.17x | 0.29x | 0.37x | 0.56x | 0.73x | 0.80x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Monash Ivf Group Ltd dividends
- Dividend yield
- 1.67%
- Forward dividend
- 0.03 AUD
- Payout ratio
- 63.0%
- Ex-dividend date
- Sep 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 4.68M | 0.01 | 63.0% |
| 2025 | AUD 19.9M | 0.05 | 79.5% |
| 2024 | AUD 18.3M | 0.05 | - |
| 2023 | AUD 17.1M | 0.04 | 78.5% |
| 2022 | AUD 16.8M | 0.04 | 91.0% |
| 2021 | AUD 13.1M | 0.03 | 52.2% |
| 2020 | AUD 7.07M | 0.02 | 60.3% |
| 2019 | AUD 13.2M | 0.05 | 66.5% |
| 2018 | AUD 18.6M | 0.08 | 87.1% |
| 2017 | AUD 20.7M | 0.09 | 69.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Monash Ivf Group Ltd
- Insiders 13.97%
- Institutions 19.47%
- Public & others 66.56%
- Shares outstanding 390M
- Free float 303M
Top funds holding MVF.AU
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| DFA International Small Cap Value Portfolio | 3.43M | 0.88% | - | Jan 2021 |
| DFA Asia Pacific Small Company Series | 1.74M | 0.45% | - | Jan 2021 |
| DFA International Core Equity Portfolio | 1.41M | 0.36% | - | Jan 2021 |
| WisdomTree Tr-WisdomTree International Small Cap Dividend Fd | 1.27M | 0.33% | - | Feb 2021 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 280K | 0.07% | - | Feb 2021 |
| DFA International Vector Equity Port | 262K | 0.07% | - | Jan 2021 |
| DFA T.A. World Ex U.S. Core Equity Portfolio | 183K | 0.05% | - | Jan 2021 |
| DFA Investment Dimensions-World Ex U.S. Core Equity Port | 164K | 0.04% | - | Jan 2021 |
| John Hancock Fds II-International Small Company Fund | 130K | 0.03% | - | Jan 2021 |
| DFA International Sustainability Core 1 Portfolio | 94.2K | 0.02% | - | Jan 2021 |
Monash Ivf Group Ltd company profile
- Company name
- Monash Ivf Group Ltd
- Ticker
- MVF.AU
- ISIN
- AU000000MVF3
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 892
- Fiscal year end
- June
- Address
- 510 Church Street, Cremorne, VIC, Australia, 3121
- Phone
- 61 3 9420 8235
- Website
- monashivfgroup.com.au
About Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Monash Ivf Group Ltd management
1- Ms. Rebecca ReddenChief Operating Officer